Learn more about our industry study - purchase by the page or the full report:

Study #: 2667

Published: 08/2010

Pages: 239

Full Study Price: US$ 4,700

Per Page Price: US$ 35.00 (text) | 60.00 (table)

Vaccines to 2014 - Market Research, Market Share, Market Size, Sales, Demand Forecast, Market Leaders, Company Profiles, Industry Trends

US demand for vaccines will advance 5.6 percent annually through 2014, driven by the development of new vaccines to treat complex human diseases, such as cancer. Public health recommendations for adult and adolescent immunization will produce continued strong sales in this segment, which has reached the level of pediatric vaccines sales.

This study analyzes the $10.8 billion US vaccines industry. It presents historical demand data for the years 1999, 2004 and 2009, and forecasts for 2014 and 2019 by vaccine type (e.g., pediatric, adult and adolescent, pandemic influenza, biodefense, developmental, travel, livestock, companion animal, poultry).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 18 industry competitors, including Sanofi-Aventis, Merck and GlaxoSmithKline.

				    TABLE OF CONTENTS

     SECTION									    PAGE

		Introduction							    VIII

	I.	Executive Summary						       1

	II.	Market Environment						       4
		General								       4
		Macroeconomic Outlook						       5
		Demographic Patterns						       8
		Health Care Trends						      11
		   Health Insurance & Reimbursement				      12
		   Medical Conditions						      14
		      Chronic Conditions					      15
		      Acute Conditions						      17
		      Reportable Diseases					      19
		   National Health Expenditures					      22
		   Medical Facilities & Professionals				      24
		   Patient Activity						      27
		Animal Health Care						      30
		   Animal Demographic Trends					      31
		   Veterinarians & Other Veterinary Workers			      32
		   Animal Health Expenditures					      33
		Regulatory Considerations					      36
		   Human Vaccines Regulation					      36
		   Animal Vaccines Regulation					      38

	III.	Vaccine Technologies						      39
		General								      39
		Technologies Used in Currently Licensed Products		      40
		Technologies Under Development					      44
		Delivery							      45
		Valence & Combined Vaccines					      46
		Efficacy							      47

	IV.	Product Overview						      49
		General								      49
		Major Product Groups						      50
		   Human Vaccines						      51
		      Recommended Childhood Immunizations			      54
		      Recommended Adult & Adolescent Immunizations		      55
		   Animal Vaccines						      57
		Historical Market Trends					      58
		International Activity & Foreign Trade				      59
		   Human Vaccines Trade						      62
		   Animal Vaccines Trade					      63

	V.	Human Vaccines							      65
		General								      65
		Pediatric Vaccines						      67
		   Combination Vaccines						      69
		      Diphtheria-Tetanus-Pertussis (DTaP)			      70
		      Measles-Mumps-Rubella (MMR)				      72
		      Other Combination Vaccines				      75
		   Pneumococcal (PCV)						      76
		   Varicella							      78
		   Rotavirus							      80
		   Hepatitis							      82
		   Haemophilus b (Hib)						      84
		   Pediatric Seasonal Influenza					      86
		   Polio							      88
		Adult & Adolescent Vaccines					      89
		   Seasonal Influenza Vaccines					      91
		   Human Papillomavirus						      95
		   Tetanus-Diphtheria-Pertussis (Tdap)				      97
		   Meningococcus						      99
		   Pneumococcus							     101
		   Hepatitis							     103
		   Herpes Zoster						     104
		   Other Adult & Adolescent Vaccines				     106
		      Varicella							     107
		      Tuberculosis						     108
		      Lyme Disease						     109
		Pandemic Influenza Vaccines					     110
		Biodefense							     113
		   Anthrax							     115
		   Smallpox							     117
		Travel Vaccines							     119
		Developmental Vaccines						     125
		   Cancer							     127
		      Prostate Cancer						     129
		      Lung Cancer						     130
		      Other Cancers						     131
		   Other Developmental Vaccines					     132
		      HIV/AIDS							     133
		      Respiratory Syncytial Virus (RSV)				     135
		      Alzheimer’s Disease					     137
		      All Other Developmental Vaccines				     138

	VI.	Animal Vaccines							     140
		General								     140
		Livestock Vaccines						     142
		   Bovine Vaccines						     143
		   Porcine Vaccines						     146
		   Ovine Vaccines						     148
		Companion Animal Vaccines					     149
		   Canine Vaccines						     151
		   Feline Vaccines						     152
		   Equine Vaccines						     153
		   Other Companion Animal Vaccines				     155
		Poultry Vaccines						     155
		Other Animal Vaccines						     158

	VII.	Industry Structure						     160
		General								     160
		Market Share							     162
		Competitive Strategies						     164
		Mergers & Acquisitions						     166
		Licensing & Related Agreements					     168
		Research & Development						     173
		Manufacturing							     174
		Marketing & Distribution					     175
		Company Profiles						     177
		   AstraZeneca plc						     178
		   Baxter International Incorporated				     180
		   Biogen Idec Incorporated					     182
		   Boehringer Ingelheim GmbH					     183
		   Crucell NV							     185
		   Dow Chemical Company						     190
		   DynPort Vaccine Company LLC					     192
		   Emergent BioSolutions Incorporated				     194
		   GenVec Incorporated						     197
		   GlaxoSmithKline plc						     199
		   Heska Corporation						     202
		   Intervet/Schering-Plough Animal Health, see Merck 
		   MedImmune LLC, see AstraZeneca 
		   Merck & Company Incorporated					     204
		   Merial Limited, see Sanofi-Aventis
		   Novartis AG							     210
		   Pfizer Incorporated						     214
		   PharmAthene Incorporated					     218
		   Sanofi-Aventis						     221
		   VaxGen Incorporated						     227
		   VaxInnate Corporation					     229
		   Wyeth, see Pfizer 
		Additional Companies Mentioned in the Study			     231


				      LIST OF TABLES

    TABLE NUMBER								    PAGE


		SECTION I -- Executive Summary
		Summary Table							       3

		SECTION II -- Market Environment
	1	Macroeconomic Indicators					       8
	2	Population & Households						      11
	3	Health Insurance Coverage of the US Population			      14
	4	Chronic Conditions by Type					      17
	5	Acute Conditions by Type					      19
	6	Specified Reportable Diseases					      21
	7	National Health Expenditures					      24
	8	Selected Medical Facilities & Professionals			      27
	9	Patient Activity						      30
	10	Animal Population						      32
	11	Animal Health Employment					      33
	12	Animal Health Expenditures					      35

		SECTION III -- Vaccine Technologies
	1	US Licensed Vaccines by Production Technology			      42

		SECTION IV -- Product Overview
	1	Vaccines Demand by Major Product Group				      51
	2	Human Vaccines Licensed for US Sale				      52
	3	2010 CDC-Recommended Childhood Immunizations			      55
	4	2010 CDC-Recommended Adolescent Immunizations			      56
	5	2010 CDC-Recommended Adult Immunizations			      56
	6	Vaccines Market, 1999-2009					      59
	7	US Trade in Vaccines						      62
	8	US Trade in Human Vaccines					      63
	9	US Trade in Animal Vaccines					      64

		SECTION V -- Human Vaccines
	1	Human Vaccines Demand						      67
	2	Pediatric Vaccines Demand by Type				      69
	3	Pediatric Combination Vaccines Demand				      70
	4	Diphtheria, Tetanus & Pertussis (DTaP)  
		   Combination Vaccines Demand					      72
	5	Measles, Mumps & Rubella (MMR) 
		   Combination Vaccines Demand					      75
	6	Other Combination Vaccines Demand				      76
	7	Pediatric Pneumococcal Vaccines Demand				      78
	8	Varicella Vaccines Demand					      80
	9	Rotavirus Vaccines Demand					      82
	10	Pediatric Hepatitis A & B Vaccines Demand			      84
	11	Haemophilus b (Hib) Vaccines Demand				      86
	12	Pediatric Seasonal Influenza Vaccines Demand			      88
	13	Polio Vaccines Demand						      89
	14	Adult & Adolescent Vaccines Demand by Group & Condition		      91
	15	Adult & Adolescent Seasonal Influenza Vaccines Demand		      95
	16	Human Papillomavirus (HPV) Vaccines Demand			      97
	17	Tetanus-Diphtheria-Pertussis (Tdap) Vaccines Demand		      99
	18	Meningococcal Vaccines Demand					     101
	19	Adult & Adolescent Pneumococcal Vaccines Demand			     103
	20	Adult & Adolescent Hepatitis A & B Vaccines Demand		     104
	21	Herpes Zoster Vaccines Demand					     106
	22	Other Adult & Adolescent Vaccines Demand			     107
	23	Pandemic Influenza Vaccines Demand				     113
	24	Biodefense Vaccines Demand					     115
	25	Travel Vaccines Demand						     120
	26	Developmental Vaccines Demand					     127
	27	Cancer Vaccines Demand						     129
	28	Other Developmental Vaccines Demand				     133

		SECTION VI -- Animal Vaccines
	1	Animal Vaccines Demand						     141
	2	Livestock Vaccines						     143
	3	Companion Animal Vaccines Demand				     150
	4	Poultry Vaccines Demand						     158
	5	Other Animal Vaccines Demand					     159

		SECTION VII -- Industry Structure
	1	US Vaccines Revenues by Company, 2009				     161
	2	Selected Acquisitions & Divestitures				     167
	3	Selected Cooperative Agreements					     171

				      LIST OF CHARTS

    CHART NUMBER								    PAGE

		SECTION VII -- Industry Structure
	1	US Human Vaccines Market Share by Company, 2009			     162
	2	US Animal Vaccines Market Share by Company, 2009		     163